SEC Form 4 · accession 0001209191-15-016795
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alta Partners VIII, L.P.
10% Owner
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 18, 2015 | J | 842,222 | $0.00 | D | 1,709,967 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro-rata in-kind distribution of Common Stock of the Issuer to the limited partners and general partner of Alta Partners VIII, L.P. without the receipt of consideration.